CT-P39 Compared with Reference Omalizumab in Chronic Spontaneous Urticaria: Results from a Double-Blind, Randomized, Active-Controlled, Phase 3 Study

Sarbjit S. Saini,Marcus Maurer, Yevgeniya Dytyatkovska, Ewa Springer, Maria Ratkova, Borislava Krusheva,Chun Wook Park, Grazyna Pulka, Marta Chelminska,Adam Reich,Sunghyun Kim,Keumyoung Ahn,Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim,Clive Grattan

ALLERGY（2025）

Cited 0|Views2

Key words

anti-IgE,biosimilar,chronic spontaneous urticaria,CT-P39,omalizumab

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined